These results indicated that BMDC-expressed AIMp1 is critical for vaccine-mediated rejection of immunogenic melanoma tumor, whereas the impact of AIMp1 in host effector cells appeared to have little relevance in this regard. Here, AIMP1 is linked to neoplasm.